Axonics Inc. (AXNX): Market Cap to Revenue

Symbol and logo of brand Axonics Inc. (AXNX)

The revenue multiple for Axonics, Inc. (AXNX) reflects the dynamics of a fabless production model with a California-based engineering center. The level of 2.70 represents the current value of this metric. Price stability is driven by the moderate cyclicality of demand for elective procedures. An impeccable reputation among global surgeons guarantees brand resilience, confirming the long-term business development trajectory shown on this chart.

AXNX Axonics Inc. P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Axonics Modulation Technologies (AXNX)

- share price and consensus valuation forecast:
Price Performance Chart axonics.com|AXNX - Price Target Chart
- stock exchange capitalization data:
Market Valuation Axonics Modulation Technologies|AXNX - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Axonics|AXNX - Book Capitalization|Capitalization to Book Value Ratio axonics.com|AXNX - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Axonics, Inc.|AXNX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Axonics, Inc|AXNX - Company Aggregate Debts|Debts to Book Capitalization Axonics Modulation Technologies|AXNX - Company Long-Term Debt|Company Short-Term Debt Axonics|Intermediate Coverage Ratio axonics.com
- earnings and multiples data:
AXNX - Net Profit|Expected Net Profit Axonics, Inc.|AXNX - Price to Earnings Ratio|Forward Price to Earnings Multiple Axonics Inc.|AXNX - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Axonics Modulation Technologies|AXNX - Operating profit EBITDA|Net earnings per share for the last four quarters Axonics|AXNX - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months axonics.com|AXNX - Earnings per share growth in current year|Expected earnings per share growth for next year Axonics, Inc.
- issuer revenue and sales details:
AXNX - Revenue and Sales Volume|Company Expected Sales Volume axonics.com|AXNX - Price-to-Revenue Ratio|Market Cap to Projected Revenue Axonics Modulation Technologies
General company analysis:AXNX axonics.com
Core merchandise of Axonics, Inc.

Axonics, Inc. generates revenue through the sale of implantable neuromodulation systems for the therapy of urological and proctological dysfunctions. By analyzing the historical P/S, an investor assesses the company's market value relative to its operating revenues, which allows for determining the degree of overpayment for the business and comparing current capitalization with the fundamental ability to generate cash flow over the long term.

Competitors of Axonics, Inc.

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - P/S Multiple|Price-to-Revenue Coefficient blade.com SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Inc)|Price-to-Revenue Ratio ClearPoint Neuro Inc.|Market Cap to Revenue Stereotaxis Corporation (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Jin Medical International - Market Cap to Sales Volume|VANI: P/S Multiple|Xtant Medical (XTNT) - P/S Multiple|Market Cap to Revenue NMTC|Market Cap to Revenue Ratio MODD (Modular Med)|Price-to-Revenue Ratio Myomo, Inc (MYO)|COCH - Price to Sales|Price-to-Revenue Ratio Vivos Therapeutics VVOS|NVNO: Market Cap to Revenue Ratio|SINTX Technologies - P/S Multiple|Price-to-Revenue Coefficient Tenon Medical Inc. TNON|LFWD: P/S Multiple|Market Cap to Revenue Autonomix Medical|Price-to-Revenue Ratio INVO Fertility Inc|bonebiologics.com (BBLG) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (BIOLASE)|DYNT (dynatronics.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple FNA (Paragon 28)|Price-to-Revenue Coefficient INVO Bioscience Inc. (INVO)